Current advances in the development of therapies for neuromuscular disorders based on myostatin signalling, 3rd International Institute of Myology Workshop, Paris, September 12th, 2008.
Faculté de Médecine Pierre et Marie Curie, Université Paris VI, UPMC INSERM UMR S 974/CNRS UMR 7215 - Institut de Myologie, 105 bd de l'Hôpital, 75013 Paris, France.
Julie
J
Dumonceaux
Helge
H
Amthor
D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D015444:Exercise; D006801:Humans; D019042:Muscle Neoplasms / Q000378:metabolism; D055435:Myostatin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009468:Neuromuscular Diseases / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D018384:Oxidative Stress / Q000502:physiology; D012208:Rhabdomyosarcoma / Q000378:metabolism; D032496:Satellite Cells, Skeletal Muscle / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction / Q000502:physiology*
D055435:Myostatin